z-logo
open-access-imgOpen Access
Sudden‐Onset Sensorineural Hearing Loss after Immunization
Author(s) -
Baxter Roger,
Lewis Ned,
Bohrer Pamela,
Harrington Theresa,
Aukes Laurie,
Klein Nicola P.
Publication year - 2016
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599816639043
Subject(s) - medicine , vaccination , confidence interval , odds ratio , immunization , pediatrics , population , tetanus , immunology , antibody , environmental health
Objective Case reports of sudden sensorineural hearing loss (SSHL) following vaccines have led to concerns that vaccines may rarely cause hearing loss. Because of this concern, we analyzed for an association between SSHL and vaccinations. Study Design We used a case‐centered method, equivalent to a case control design using immunization dates from all matched members of the population to calculate exposure to vaccines, rather than sampling. Setting Kaiser Permanente Northern California (KPNC), 2007 to 2013. Subjects and Methods We searched KPNC databases from 2007 to 2013 for all first‐time diagnoses of SSHL. We used the date of any hearing‐ or ear‐related visit in the 60 days prior to the first SSHL diagnosis as the onset date. Using only SSHL cases immunized in the prior 9 months, we compared the vaccine exposure in several risk intervals prior to onset with the exposure to the same vaccine during the same time period in all KPNC membership, matched to sex and age. Results During the study period, >20 million vaccines were administered at KPNC. In all risk intervals prior to onset of SSHL, we found no evidence of increased risk of immunization compared with matched controls. The odds ratios for vaccination 1 week prior to SSHL were 0.965 (95% confidence interval, 0.61‐1.50) for trivalent inactivated influenza vaccine (TIV); 0.842 (0.39‐1.62) for tetanus, reduced diphtheria, and reduced acellular pertussis; and 0.454 (0.08‐1.53) for zoster vaccine. Conclusion A large‐scale analysis applying a case‐centered method did not detect any association between SSHL and previous receipt of TIV or other vaccines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here